Brain Image Analysis Program icobrain (Formerly MSmetrix) Notice of Change of Sales Name and Start of Sales

Micron Co., Ltd. (Micron, Head Office: Chuo-ku, Tokyo, Representative Director: Michita Sato) with icometrix NV (icometrix, Head Office: Ruben, Belgium, CEO: Wim Van Hecke) in regards to icobrain, the brain image analysis service, has acquired certification based on the Pharmaceuticals and Medical Devices Act, etc., and will begin offering it to domestic medical institutions on May 12, 2018.

Sales Name: Brain image analysis program icobrain

Authentication Number: 230ALBZX00010A01

Manufacturer and Seller: Micron

Foreign Registered Manufacturer: icometrix NV

If you have any questions or inquiries regarding this matter, please contact the following:

Micron Corporation

icobrain sales contact email address: icobrain@micron-kobe.com

About the Brain Image Analysis Program icobrain

The brain image analysis program icobrain is a brain MR image analysis software program for patients with neurodegeneration.

Based on clinical MR images, it can provide clinicians with easily interpretable reports. The reports include population graphs and statistics that can objectively track the progress of disease in individual patients. Using icometrix’s patented technology, it is possible to accurately compare MR images acquired at different times. It can be easily integrated into a hospital information system or PACS and it can be part of a regular workflow.

About icometrix NV

icometrix was founded in 2011 at one of the leading Belgian universities and spin-off companies from university hospitals in Leuven and Antwerp. Currently, icometrix has offices in Ruben (Belgium) and Boston (USA) and is active internationally. The icobrain service has been approved by the FDA and has been approved for marketing in Europe, Canada, South America, and Australia. icometrix has acquired ISO 13485 (medical device) and ISO 27001 (information security), and it complies with HIPAA regarding safety and privacy rules.